Therapeutic Potential of Combining PARP Inhibitor and Immunotherapy in Solid Tumors

Immunotherapy has revolutionized the treatment of both hematological malignancies and solid tumors. The use of immunotherapy has improved outcome for patients with cancer across multiple tumor types, including lung, melanoma, ovarian, genitourinary, and more recently breast cancer with durable respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Vikas, Praveen, Borcherding, Nicholas, Chennamadhavuni, Adithya, Garje, Rohan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228136/
https://www.ncbi.nlm.nih.gov/pubmed/32457830
http://dx.doi.org/10.3389/fonc.2020.00570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228136/
https://www.ncbi.nlm.nih.gov/pubmed/32457830
http://dx.doi.org/10.3389/fonc.2020.00570

Ejemplares similares